Driven by Rising Geriatric Population and disease Prevalence, The Molecular Diagnostics market Grows Steadily, Focusing On DNA and Bimolecular Innovations.

"Build your enemy a golden bridge to retreat across" is a piece of advice offered by Sun Tzu in his ancient military treatise, The Art of War.

Hologic took on considerable leverage after its $3.8 billion acquisition of Gen-Probe in 2012, but deleveraged in the ensuing years and avoided piling on more debt for the purchase of Cynosure. As of ...

A team of researchers used a new technique, called high-resolution template matching, or HRTM, to uncover in unprecedented detail the movement of ribosomes -- the molecular structures that synthesize ...

Changes can be identified with near-perfect precision by compact, portable scanners within a matter of hours. Different types ...

Breast cancer continues to pose a significant global health challenge as the most commonly diagnosed cancer in women ...

The agency made multiple decisions regarding coverage for diagnostic and laboratory testing that have affected the industry.

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid in identifying colorectal cancer in early stages. Through polymerase chain reaction (PCR) technology, ...

The molecular causes of ALS are poorly understood ... Researchers hope that this new lab-based model of ALS will help to ...

Artificial intelligence (AI) based on machine learning offers opportunities for the life sciences. However, problems often ...

Identification of individuals at high risk of developing cancer (based on models integrating clinical, demographic and molecular data) will assist in selecting optimal populations for ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.